A methylcellulose and collagen based temperature responsive hydrogel promotes encapsulated stem cell viability and proliferation in vitro
With the number of stem cell-based therapies emerging on the increase, the need for novel and efficient delivery technologies to enable therapies to remain in damaged tissue and exert their therapeutic benefit for extended periods, has become a key requirement for their translation. Hydrogels, and in particular, thermoresponsive hydrogels, have the potential to act as such delivery systems. Thermoresponsive hydrogels, which are polymer solutions that transform into a gel upon a temperature increase, have a number of applications in the biomedical field due to their tendency to maintain a liquid state at room temperature, thereby enabling minimally invasive administration and a subsequent ability to form a robust gel upon heating to physiological temperature. However, various hurdles must be overcome to increase the clinical translation of hydrogels as a stem cell delivery system, with barriers including their low tensile strength and their inadequate support of cell viability and attachment. In order to address these issues, a methylcellulose based hydrogel was formulated in combination with collagen and beta glycerophosphate, and key development issues such as injectability and sterilisation processes were examined. The polymer solution underwent thermogelation at ~36 °C as determined by rheological analysis, and when gelled, was sufficiently robust to resist significant disintegration in the presence of phosphate buffered saline (PBS) while concomitantly allowing for diffusion of methylene blue dye solution into the gel. We demonstrate that human mesenchymal stem cells (hMSCs) encapsulated within the gel remained viable and showed raised levels of dsDNA at increasing time points, an indication of cell proliferation. Mechanical testing showed the “injectability”, i.e. force required for delivery of the polymer solution through devices such as a syringe, needle or catheter. Sterilisation of the freeze-dried polymer wafer via gamma irradiation showed no adverse effects on the formed hydrogel characteristics. Taken together, these results indicate the potential of this gel as a clinically translatable delivery system for stem cells and therapeutic molecules in vivo.
KeywordsMesenchymal stem cells Thermoresponsive Hydrogel Methylcellulose Collagen Gamma irradiation Injectability
human mesenchymal stem cells
standard error of mean
A bursary to allow for this work to be carried out was provided by the School of Pharmacy, Royal College of Surgeons in Ireland.
Compliance with ethical standards
Conflict of interests
The authors declare that they have no conflict of interest.
- 4.D. N. Kotton, B. Y. Ma, W. V Cardoso, E. A. Sanderson, R. S. Summer, M. C. Williams, and A. Fine, “Bone marrow-derived cells as progenitors of lung alveolar epithelium.,” Development, vol. 128, no. 24, pp. 5181–5188, 2001.Google Scholar
- 7.O’Neill HS, Gallagher LB, O’Sullivan J, Whyte W, Curley C, Dolan E, Hameed A, O’Dwyer J, Payne C, O’Reilly D, Ruiz-Hernandez E, Roche ET, O’Brien FJ, Cryan SA, Kelly H, Murphy B, Duffy GP. Biomaterial-enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives. Adv Mater. 2016:5648–61.Google Scholar
- 15.A. C. Gaffey, M. H. Chen, C. M. Venkataraman, A. Trubelja, C. B. Rodell, P. V Dinh, G. Hung, J. W. MacArthur, R. V Soopan, J. A. Burdick, and P. Atluri, “Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.,” J Thorac Cardiovasc Surg, vol. 150, no. 5, pp. 1268–1277, 2015.Google Scholar
- 19.Hastings CL, Kelly HM, Murphy MJ, Barry FP, O’Brien FJ, Duffy GP. Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. J Control Release. 2012;161(1):73–80.CrossRefPubMedGoogle Scholar
- 24.Buwalda SJ, Boere KWM, Dijkstra PJ, Feijen J, Vermonden T, Hennink WE. Hydrogels in a historical perspective: from simple networks to smart materials. J Control Release. 2014;190:254–73.Google Scholar
- 39.Nichols JE, Kojima K, Bonassar LJ, Dargon P, Roy AK, Vacant MP, et al. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006;12(5):1213–25.Google Scholar
- 42.C. of Europe, European Pharmacopoeia, 5.0., no. 1. Strasbourg, 2005.Google Scholar
- 47.E. T. Roche, C. L. Hastings, S. A. Lewin, D. E. Shvartsman, Y. Brudno, N. V Vasilyev, F. J. O’Brien, C. J. Walsh, G. P. Duffy, and D. J. Mooney, “Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.,” Biomaterials, vol. 35, no. 25, pp. 6850–6858, 2014.Google Scholar
- 60.Nowak AP, Breedveld V, Pakstis L, Ozbas B, Pine DJ, Pochan D, et al. Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature. 2002;417(6887):424–8.Google Scholar